Structure-Guided Inhibitor Design Expands the Scope of Analog-Sensitive Kinase Technology
Chao Zhang(University of Alabama at Birmingham), Kevan M. Shokat(Howard Hughes Medical Institute), Arvin C. Dar(Memorial Sloan Kettering Cancer Center), Michael J. Eck(Harvard University), Cai‐Hong Yun(Harvard University), Steven Finkbeiner(Gladstone Institutes), Michael S. Lopez(Howard Hughes Medical Institute), Eva LaDow(Gladstone Institutes)
Cited by 59
Related Papers
<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
|Science|2004|9.4k
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
|Cancer Cell|2005|3k
K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
|Nature|2013|2.5k
RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
|Nature|2010|1.8k
IRE1 Signaling Affects Cell Fate During the Unfolded Protein Response
|Science|2007|1.4k